Evidence on port-locking with heparin versus saline in patients with cancer not receiving chemotherapy: A randomized clinical trial

被引:0
作者
Cia-Arriaza, Melania [1 ]
Cabrera-Jaime, Sandra [1 ,2 ,3 ]
-Soria, Rosario Cano [1 ]
Manzano-Castro, Mireia [4 ]
Dominguez-Gomez, Margarita [4 ]
Prieto-Arenas, Dolores M. [4 ]
Benito-Yaguee, Angeles [4 ]
Sanchez-Martin, Adela [4 ]
Gonzalez-Alonso, Cristina [4 ]
Fernandez-Ortega, Paz [2 ,3 ,5 ]
机构
[1] Hosp Germans Trias i Pujol, Catalan Inst Oncol Badalona, Badalona, Spain
[2] Inst Biomed Res, GRIN Grp, IDIBELL, Barcelona, Spain
[3] Univ Barcelona, Fac Hlth Sci, Nursing Sch, Barcelona, Spain
[4] Catalan Inst Oncol ICO, Barcelona, Spain
[5] Catalan Inst Oncol ICO, Nursing Res Unit, Barcelona, Spain
关键词
Central venous catheters; Port; Heparin; Obstruction; Complications; Nursing care; Cancer patient; VASCULAR ACCESS DEVICES; CATHETER; ONCOLOGY; MAINTENANCE; INTERVAL;
D O I
10.1016/j.apjon.2022.100085
中图分类号
R47 [护理学];
学科分类号
1011 ;
摘要
Objective: To assess the safety and efficacy of port-locking with heparin every 2 months vs. every 4 months and vs. saline solution every 2 months in patients with cancer not receiving active chemotherapy. The hypothesis stated that locking with heparin at four-month intervals and saline at two-month intervals would not increment > 10% of port obstructions. Methods: Multicentre, phase IV parallel, post-test control group study took place at the two chemotherapy units of oncology hospitals. Included patients with cancer with ports that completed the chemotherapy treatment but still having port maintenance care or blood samples taken up to four months. A sample of 126 patients with cancer in three arms was needed to detect a maximum difference of 10% for bioequivalence on the locking methods. Consecutive cases non-probabilistic sampling and randomized to one of the three groups; group A: received heparin 60 IU/mL every two months (control) vs. group B heparin every four months and vs. saline every two months in group C. Primary variables were the type of locking regimen, port obstruction, and absence of blood return, port-related infection, or venous thrombosis during the study period. Clinical and sociodemographic variables were also collected. Results: A total of 143 patients were randomly assigned; group A, 47 patients with heparin every 2 months, group B, 51 patients with heparin 4 months, and group C, 45 patients with saline every 2 months. All participants presented an adequate blood return and no obstructions, until the month of the 10th, when one participant in the group A receiving was withdrawn due to an absence of blood flow ( P 1/4 0.587). Conclusions: Port locks with heparin every 4 months or saline every 2 months did not show differences in safety maintenance, infection, or thrombosis compared to heparin every 2 months.
引用
收藏
页数:6
相关论文
共 27 条
[1]  
[Anonymous], 2008, ENE-REV ENFERM, V2, P45
[2]   Extending the interval of flushing procedures of totally implantable vascular access devices in cancer patients: It is time for a change [J].
Bertoglio, Sergio .
JOURNAL OF VASCULAR ACCESS, 2021, 22 (05) :689-691
[3]   Efficacy of Normal Saline Versus Heparinized Saline Solution for Locking Catheters of Totally Implantable Long-Term Central Vascular Access Devices in Adult Cancer Patients [J].
Bertoglio, Sergio ;
Solari, Nicola ;
Meszaros, Paolo ;
Vassallo, Francesca ;
Bonvento, Maura ;
Pastorino, Simona ;
Bruzzi, Paolo .
CANCER NURSING, 2012, 35 (04) :E35-E42
[4]   Short Versus Long Timing of Flushing of Totally Implantable Venous Access Devices When Not Used Routinely A Systematic Review and Meta-analysis [J].
Clari, Marco ;
Spoto, Maria ;
Franceschi, Giordana ;
Acuto, Martina ;
Tonella, Simone ;
Caristia, Silvia ;
Buratti, Giulia ;
Gaboardi, Samanta ;
Rasero, Laura ;
Campagna, Sara ;
Busca, Erica ;
Dal Molin, Alberto .
CANCER NURSING, 2021, 44 (03) :205-213
[5]  
Conley SB, 2017, J INFUS NURS, V40, P165, DOI 10.1097/NAN.0000000000000217
[6]   Normal saline versus heparin solution to lock totally implanted venous access devices: Results from a multicenter randomized trial [J].
Dal Molin, Alberto ;
Clerico, Mario ;
Baccini, Michela ;
Guerretta, Linda ;
Sartorello, Barbara ;
Rasero, Laura .
EUROPEAN JOURNAL OF ONCOLOGY NURSING, 2015, 19 (06) :638-643
[7]   The late complications of totally implantable central venous access ports: The results from an Italian multicenter prospective observation study [J].
Dal Molin, Alberto ;
Rasero, Laura ;
Guerretta, Linda ;
Perfetti, Elisa ;
Clerico, Mario .
EUROPEAN JOURNAL OF ONCOLOGY NURSING, 2011, 15 (05) :377-381
[8]  
Dougherty L, 1998, SUPPORT CARE CANCER, V6, P23
[9]   Implanted Port Patency Comparing heparin and normal saline [J].
Egnatios, Donna ;
Gloria, Crystle .
CLINICAL JOURNAL OF ONCOLOGY NURSING, 2021, 25 (02) :169-+
[10]   Eight-week interval in flushing and locking port-a-cath in cancer patients: A single-institution experience and systematic review [J].
Fornaro, Carla ;
Piubeni, Maria ;
Tovazzi, Valeria ;
Cosentini, Deborah ;
Gelmi, Maria ;
Rota, Gabriella ;
Berta, Barbara ;
Barucco, Wilma ;
Lombardi, Eleonora ;
Moles, Luisa ;
Faustini, Tiziana ;
Fettolini, Tiziana ;
Motta, Paolo ;
Ferrari, Vittorio D. ;
Berruti, Alfredo ;
Conti, Elisabetta .
EUROPEAN JOURNAL OF CANCER CARE, 2019, 28 (02)